DexCom, Inc. DXCM NASDAQ

DexCom, Inc. (DXCM) generated $1.44B in operating cash flow for fiscal year 2025. After capital expenditures of $363.5M, free cash flow was $1.08B.

Free cash flow margin was 23.1% of revenue. Cash conversion ratio was 1.72x, indicating earnings are backed by cash.

The company returned $500M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (71/100, Pass) — $1.08B (23.1% FCF margin) supports a durable competitive advantage
• INCOME (70/100) — Cash conversion ratio was 1.72x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 82/100 with 7/7 criteria passed.